PreOmics Secures €3.3M Series A Funding to Advance Innovative Mass Spectrometry Sample Preparation Technologies

On January 2, 2019, VCBeat (WeChat Official Account: vcbeat) learned that PreOmics, a company based in Martinsried, Germany, officially announced on December 27, 2018, that it had raised €3.3 million in its Series A financing round. The company is primarily engaged in the development and production of innovative technologies for pre-analytical sample preparation in mass spectrometry analysis.

This funding round was led by Think.Health Ventures, with participation from High-Tech Gründerfonds and business angels. The company plans to use the proceeds to continue its international expansion and develop additional products.

It is understood that PreOmics was co-founded by Garwin Pichler and Nils Kulak in August 2016, holding the intellectual property rights from Matthias Mann’s laboratory at the Max Planck Institute of Biochemistry. PreOmics primarily develops and provides innovative mass spectrometry-based proteomics technologies, aiming to deliver optimal solutions for biological research. Its mission is to simplify various biotechnological studies by ensuring the highest quality while making processes faster, easier, and more reliable.

It is worth noting that PreOmics has addressed numerous biotechnological challenges through standardized technologies, ensuring reproducible results in sample preparation. Furthermore, this technology significantly reduces workload compared to traditional methods.

PreOmics is a company spun out of the proteomics research group led by Matthias Mann, a pioneer at the Max Planck Institute of Biochemistry.

The founding team of PreOmics began optimizing LC-MS proteomics workflows in the Matthias Mann laboratory in 2010. In 2014, Dr. Nils A. Kulak and Dr. Garwin Pichler established an optimized, simplified sample preparation protocol and began validating their technology with external laboratories and researchers. With the support of numerous proteomics experts, engineers, and industrial designers, they developed their first off-the-shelf product.

The PreOmic team has received multiple awards for its business concept, gained support from various accelerator programs, and established its own company in early 2016. Currently, the company is located at the IZB (Innovation and Start-up Center) in Martinsried, south of Munich.

Think.Health Ventures is a small-scale medical risk bearer that continuously seeks innovative and disruptive business models in the fields of digital health, medical technology, and healthcare services.

High-Tech Gründerfonds (HTGF), launched in 2005, is a powerful engine driving the development of high-tech startups.

HTGF primarily focuses on investing in high-potential startups active in sectors such as software, media, the Internet, hardware, energy and automation, life sciences (medical technology, diagnostics, biotechnology), and chemicals.